Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision

Reuters

08 May

Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision

Palatin Technologies Inc., a biopharmaceutical company, has announced that its common stock will be delisted from the NYSE American due to its low selling price. Trading on the NYSE American was immediately suspended, and the stock will transition to the OTC Pink Market under the ticker symbol "PTNT" starting May 8, 2025. The company plans to appeal the delisting decision, with a deadline for the appeal set for May 14, 2025. Despite the delisting, Palatin's President and CEO, Carl Spana, expressed confidence in the company's assets and commitment to advancing their business plan.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palatin Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH83024) on May 08, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2533092990"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533092990\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2533092990?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-08 08:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533092990","market":"us","top_or_hot":-1,"title":"Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PTN\">Palatin Technologies Inc</a>., a biopharmaceutical company, has announced that its common stock will be delisted from the NYSE American due to its low selling price. Trading on the NYSE American was immediately suspended, and the stock will transition to the OTC Pink Market under the ticker symbol \"PTNT\" starting May 8, 2025. The company plans to appeal the delisting decision, with a deadline for the appeal set for May 14, 2025. Despite the delisting, Palatin's President and CEO, Carl Spana, expressed confidence in the company's assets and commitment to advancing their business plan.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palatin Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH83024) on May 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-05-08 08:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        <a href=\"https://laohu8.com/S/PTN\">Palatin Technologies Inc</a>., a biopharmaceutical company, has announced that its common stock will be delisted from the NYSE American due to its low selling price. Trading on the NYSE American was immediately suspended, and the stock will transition to the OTC Pink Market under the ticker symbol \"PTNT\" starting May 8, 2025. The company plans to appeal the delisting decision, with a deadline for the appeal set for May 14, 2025. Despite the delisting, Palatin's President and CEO, Carl Spana, expressed confidence in the company's assets and commitment to advancing their business plan.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palatin Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH83024) on May 08, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PTNT","symbol_name":"Palatin Technologies, Inc.","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250508:nNDL94n0vt:1","article_id":"2533092990","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533092990","pubTimestamp":1746664013,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Palatin Technologies Inc., a biopharmaceutical company, has announced that its common stock will be delisted from the NYSE American due to its low selling price. Trading on the NYSE American was immediately suspended, and the stock will transition to the OTC Pink Market under the ticker symbol \"PTNT\" starting May 8, 2025. The company plans to appeal the delisting decision, with a deadline for the appeal set for May 14, 2025. Despite the delisting, Palatin's President and CEO, Carl Spana, expressed confidence in the company's assets and commitment to advancing their business plan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palatin Technologies Inc. published the original content used to generate this news brief via PR Newswire  on M","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PTNT":"Palatin Technologies, Inc.","BK4139":"生物科技","PTN":"Palatin Technologies Inc"},"translate_title":"Palatin Technologies将在纽约证券交易所美国退市期间过渡到场外粉红市场，计划对决定提出上诉","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PTN":0.9,"PTNT":0.9},"content_text":"Palatin Technologies to Transition to OTC Pink Market Amid NYSE American Delisting, Plans to Appeal Decision\n    \n\nPalatin Technologies Inc., a biopharmaceutical company, has announced that its common stock will be delisted from the NYSE American due to its low selling price. Trading on the NYSE American was immediately suspended, and the stock will transition to the OTC Pink Market under the ticker symbol \"PTNT\" starting May 8, 2025. The company plans to appeal the delisting decision, with a deadline for the appeal set for May 14, 2025. Despite the delisting, Palatin's President and CEO, Carl Spana, expressed confidence in the company's assets and commitment to advancing their business plan.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palatin Technologies Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: PH83024) on May 08, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}